Klinger W, Oelschläger H, Karge E, Rothley D
Institut für Pharmakologie und Toxikologie, Friedrich-Schiller-Universität, Jena, Germany.
Eur J Drug Metab Pharmacokinet. 1997 Apr-Jun;22(2):165-71. doi: 10.1007/BF03189801.
Chlormezanone binds to oxidized cytochrome P450 in rat liver microsomes with a binding curve according to type I like hexobarbital but less pronounced and with a general shift to the left. Ethylmorphine N-demethylation, ethoxycoumarin and ethoxyresorufin O-deethylation are inhibited by chlormezanone in mM concentrations only whereas pentoxyresorufin O-depentylation is inhibited by about 50% in microM concentrations. Luminol and lucigenin amplified chemiluminescence indicating the formation of reactive oxygen species was not influenced in concentration ranges between mM and microM, whereas NADPH/Fe stimulated lipid peroxidation showed a tendency of inhibition. But scavenger activity could not be demonstrated: the zymosan stimulated chemiluminescence of whole blood was not influenced significantly. The degradation process of chlormezanone was elucidated. The first step involves ring opening by chemical hydrolysis with subsequent formation of an unstable acylhalfaminal which is the source of 4-chlorobenzaldehyde. This aldehyde undergoes enzymatically controlled oxidation to 4-chlorobenzoic acid which is the parent compound of following phase II reactions. The second degradation product is 2-carboxyethane-sulfinic-acid-N-methylamide, which is hydrolyzed very quickly. Neither oxidation of the sulfinic acid or its N-methylamide derivative could be observed nor N-demethylation of chlormezanone.
氯美扎酮与大鼠肝微粒体中氧化型细胞色素P450结合,其结合曲线类似于己巴比妥的I型,但不太明显,且整体向左偏移。氯美扎酮仅在毫摩尔浓度下抑制N - 脱甲基化、乙氧基香豆素和乙氧基试卤灵的O - 脱乙基化,而在微摩尔浓度下戊氧基试卤灵的O - 脱戊基化被抑制约50%。毫摩尔至微摩尔浓度范围内,鲁米诺和光泽精放大的化学发光表明活性氧的形成未受影响,而NADPH/铁刺激的脂质过氧化有抑制趋势。但未显示清除剂活性:酵母聚糖刺激的全血化学发光未受显著影响。阐明了氯美扎酮的降解过程。第一步涉及通过化学水解开环,随后形成不稳定的酰半胺,它是4 - 氯苯甲醛的来源。该醛经酶促控制氧化为4 - 氯苯甲酸,它是后续II相反应的母体化合物。第二个降解产物是2 - 羧基乙烷 - 亚磺酸 - N - 甲基酰胺,其水解非常快。未观察到亚磺酸或其N - 甲基酰胺衍生物的氧化,也未观察到氯美扎酮的N - 脱甲基化。